Week 0 + 1 Flashcards
Drug Development Part 1
In-vitro and In-Vivo testing:
Basic Research, early discovery, pre clinical
Meant to establish drug safety and efficacy
Drug Development Part 2
Human testing: Clinical Development
Phase 1: 10s of people
Phase 2: 100s of people
Phase 3: 1000s of people
Drug Development Part 3
Data Review=> FDA Review
Drug Development Part 4
Surveillance: Post-market monitoring
What protein allows SARS-CoV-1 to infect humans that some animals do not have?
ACE2R Receptor
What enzyme, if blocked, would inhibit viruses from infecting humans?
RNA dependent polymerase
What is Log P
Measure of lipophilicity of a molecule. Known as the octanol/water partition coefficient. Octanol is a representative of a lipophilic environment. Log P correlates to drug absorption and distribution in the body
To classify a drug as soluble in water. The log P must be?
Less than 0.5
Lipinski’s rule of Five
Provides a basis of whether a chemical compound is likely to become a drug.
- A molecular weight under 500
- Fewer than 10 H-bond acceptors
- Fewer than 5 H-bond donors
- A C log P value less than 5
Define a hydrogen bond donor (HBD)
A functional group that provides the hydrogen required for a hydrogen bond (When a hydrogen is bonded to another element)
Define a hydrogen bond acceptor (HBA)
Functional group that provides the electron-rich atom required to interact with a hydrogen in a hydrogen bond (A good hba has to be electronegative and have a lone pair of electrons) Such an Oxygen having extra electrons
Percentage of drugs approved in clinical trials
0.01%
Percentage of drug trials that become approved via passing each step?
Less than 10%
What is the Investigational New Drug Application (IND)
A document for drug trials
Phase 1 of drug trials
Tests healthy volunteers (unless for cancer pts, then phase 1 studies pts with cancer)
Absorption, distribution, metabolism, or excretion of drug
Side effects
Dosage and best route of administration determined
Approx. 70% of drugs move to the next phase